Explore the vast range of titles available.

The assessment of sarcopenia is part of the nutritional assessment index and is essential in stroke management. This study aimed to identify and validate cutoff values of temporal muscle thickness (TMT) measured using computed tomography to identify sarcopenia after acute stroke. The participants were patients with stroke aged ≥65 years who were admitted to rehabilitation units. The recruited patients were randomly divided into the calculation and validation cohort. In the calculation cohort, TMT cutoff values for identifying sarcopenia were calculated using receiver operating characteristic analysis. The obtained values were validated in the validation cohort using sensitivity and specificity. The calculation cohort included 230 patients (125 men, mean age, 77.2 ± 7.2 years), whereas the validation cohort included 235 patients (125 men, mean age, 76.4 ± 6.95 years). The TMT cutoff values for identifying sarcopenia and low skeletal muscle index were the same: 3.83 mm for men and 2.78 mm for women. The TMT cutoff value for identifying sarcopenia showed a sensitivity and specificity of 0.642 and 0.750, respectively, for men, and 0.660 and 0.567, respectively, for women. We identified a valid cutoff value of temporal muscle thickness for identifying sarcopenia after acute stroke. TMT is easy to measure and may be useful for the early detection of sarcopenia.

Functional electrical stimulation (FES) can support functional restoration of a paretic limb post-stroke. Hebbian plasticity depends on temporally coinciding pre- and post-synaptic activity. A tight temporal relationship between motor cortical (MC) activity associated with attempted movement and FES-generated visuo-proprioceptive feedback is hypothesized to enhance motor recovery. Using a brain–computer interface (BCI) to classify MC spectral power in electroencephalographic (EEG) signals to trigger FES-delivery with detection of movement attempts improved motor outcomes in chronic stroke patients. We hypothesized that heightened neural plasticity earlier post-stroke would further enhance corticomuscular functional connectivity and motor recovery. We compared subcortical non-dominant hemisphere stroke patients in BCI-FES and Random-FES (FES temporally independent of MC movement attempt detection) groups. The primary outcome measure was the Fugl-Meyer Assessment, Upper Extremity (FMA-UE). We recorded high-density EEG and transcranial magnetic stimulation-induced motor evoked potentials before and after treatment. The BCI group showed greater: FMA-UE improvement; motor evoked potential amplitude; beta oscillatory power and long-range temporal correlation reduction over contralateral MC; and corticomuscular coherence with contralateral MC. These changes are consistent with enhanced post-stroke motor improvement when movement is synchronized with MC activity reflecting attempted movement.

Background Dual transcranial direct current stimulation (tDCS) over the bilateral primary somatosensory cortex (PSC) has potential benefits in stroke. In addition, compared with traditional rehabilitation training, sensorimotor training can significantly improve the sensorimotor function of patients. However, the efficacy of dual‐tDCS combined with sensorimotor training in patients with subacute stroke is unknown. Objective To assess whether dual‐tDCS may enhance the efficacy of sensorimotor training on the upper limb functions in patients with subacute stroke. In addition, this study aims to explore the potential clinical mechanism of this combination therapy. Methods We randomized 52 individuals with first‐ever, unilateral subcortical stroke into the experimental group (n = 26) and the control group (n = 26). Patients in the experimental group received 20 min of dual‐tDCS over the PSC and 40 min of sensorimotor training each session, while patients in the control group received sham dual‐tDCS. The treatment cycle was a 1‐h session of therapy each day, 5 days per week for 4 weeks. The Fugl–Meyer Assessment of Upper Extremity (FMA–UE) subscale, Action Research Arm Test (ARAT), Box and Block test (BBT), Erasmus MC revised Nottingham sensory assessment scale (Em‐NSA), Neurometer sensory nerve quantitative detector (CPT), the Barthel index (BI), and Hospital Anxiety and Depression Scale (HADS) were used to assess upper limb function, activities of daily living (ADL), and mental health before and after the 4‐week treatment period. In addition, functional near‐infrared spectroscopy (fNIRS) was used to explore potential clinical brain mechanisms. Results Both groups showed significant improvement in all clinical scales (All p < 0.05) after treatment. Compared with sham‐tDCS plus sensorimotor training, active dual‐tDCS coupled with sensorimotor training can significantly improve the FMA‐UE, ARAT, Em‐NSA‐Stereognosis, and CPT‐2K Hz. In addition, dual‐tDCS combined with sensorimotor training can significantly activate the left pre‐Motor and supplementary motor cortex (PM–SMC) and enhance the functional connection between the left somatosensory association cortex (SAC) and RPM–SMC. Furthermore, the difference of FMA–UE in the experimental group was positively correlated with the functional connectivity of RPM‐SMC‐LSAC (r = 0.815, p < 0.001). Conclusion Dual‐tDCS over the PSC combined with sensorimotor training can improve upper limb sensory and motor dysfunction, enhance ADL, and alleviate depression and anxiety for subacute stroke patients. Our results indicated that RPM‐SMC‐LSAC may be potential therapeutic targets for dual‐tDCS in upper limb rehabilitation on stroke. Dual‐tDCS combined with sensorimotor training can improve upper limb sensory and motor dysfunction, enhance ADL, alleviate depression and anxiety, and enhance the functional connectivity of sensorimotor functional brain cortex for subacute stroke patients.

Background Robotic rehabilitation after stroke provides the potential to increase and carefully control dosage of therapy. Only a small number of studies, however, have examined robotic therapy in the first few weeks post-stroke. In this study we designed robotic upper extremity therapy tasks for the bilateral Kinarm Exoskeleton Lab and piloted them in individuals with subacute stroke. Pilot testing was focused mainly on the feasibility of implementing these new tasks, although we recorded a number of standardized outcome measures before and after training. Methods Our team developed 9 robotic therapy tasks to incorporate feedback, intensity, challenge, and subject engagement as well as addressing both unimanual and bimanual arm activities. Subacute stroke participants were assigned to a robotic therapy (N = 9) or control group (N = 10) in a matched-group manner. The robotic therapy group completed 1-h of robotic therapy per day for 10 days in addition to standard therapy. The control group participated only in standard of care therapy. Clinical and robotic assessments were completed prior to and following the intervention. Clinical assessments included the Fugl-Meyer Assessment of Upper Extremity (FMA UE), Action Research Arm Test (ARAT) and Functional Independence Measure (FIM). Robotic assessments of upper limb sensorimotor function included a Visually Guided Reaching task and an Arm Position Matching task, among others. Paired sample t-tests were used to compare initial and final robotic therapy scores as well as pre- and post-clinical and robotic assessments. Results Participants with subacute stroke (39.8 days post-stroke) completed the pilot study. Minimal adverse events occurred during the intervention and adding 1 h of robotic therapy was feasible. Clinical and robotic scores did not significantly differ between groups at baseline. Scores on the FMA UE, ARAT, FIM, and Visually Guided Reaching improved significantly in the robotic therapy group following completion of the robotic intervention. However, only FIM and Arm Position Match improved over the same time in the control group. Conclusions The Kinarm therapy tasks have the potential to improve outcomes in subacute stroke. Future studies are necessary to quantify the benefits of this robot-based therapy in a larger cohort. Trial registration: ClinicalTrials.gov, NCT04201613, Registered 17 December 2019—Retrospectively Registered, https://clinicaltrials.gov/ct2/show/NCT04201613 .

Dysarthria is a motor speech disorder frequently associated with subcortical damage. However, the precise roles of the subcortical nuclei, particularly the basal ganglia and thalamus, in the speech production process remain poorly understood. The present study aimed to better understand their roles by mapping neuroimaging, behavioral, and speech data obtained from subacute stroke patients with subcortical lesions. Multivariate lesion-symptom mapping and voxel-based morphometry methods were employed to correlate lesions in the basal ganglia and thalamus with speech production, with emphases on linguistic processing and articulation. The present findings revealed that the left thalamus and putamen are significantly correlated with concept preparation ( = 0.64, < 0.01) and word retrieval ( = 0.56, < 0.01). As the difficulty of the behavioral tasks increased, the influence of cognitive factors on early linguistic processing gradually intensified. The globus pallidus and caudate nucleus were found to significantly impact the movements of the larynx ( = 0.63, < 0.01) and tongue ( = 0.59, = 0.01). These insights underscore the complex and interconnected roles of the basal ganglia and thalamus in the intricate processes of speech production. The lateralization and hierarchical organization of each nucleus are crucial to their contributions to these speech functions. The present study provides a nuanced understanding of how lesions in the basal ganglia and thalamus impact various stages of speech production, thereby enhancing our understanding of the subcortical neuromechanisms underlying dysarthria. The findings could also contribute to the identification of multimodal assessment indicators, which could aid in the precise evaluation and personalized treatment of speech impairments.

Introduction Transcranial focused ultrasound (tFUS), a non-invasive brain neuromodulation, can target deeper and more precise brain regions compared to transcranial magnetic stimulation. However, its safety, neuromodulation and therapeutic effects in subacute stroke patients remain unclear. Therefore, the aim of this project is to demonstrate the safety and preliminary efficacy of tFUS for upper limb motor recovery in subacute stroke patients. Methods In this phase I single-arm study, we recruited 10 patients with subacute (≤ 3 months) unilateral stroke. tFUS was applied to the contralesional M1 by neuronavigation once daily for five sessions, using I SPTA 2.8 W/cm² in free field (estimated in situ < 0.3 W/cm²), MI 0.75, PRF 100 Hz, and duty cycle 30%, with 10-minute exposure per session. The primary outcome was safety over 12 weeks. Secondary outcomes included cortical excitability (evaluated by transcranial magnetic stimulation and functional near-infrared spectroscopy) and functional measures assessed pre-treatment and at 1 day, 1 week, 4 weeks, and 12 weeks.) Results Ten patients completed the trial, and the safety analysis revealed no severe adverse events (AEs), new imaging abnormalities, or neuropsychological decline; only minor transient AEs occurred in 5 of 10 patients. tFUS showed preliminary therapeutic efficacy, with improvements in hemiplegic upper limb motor recovery and functional performance. Greater FMA improvement was observed in the tFUS group compared with age-, sex-, and baseline FMA-matched patients who received rTMS. Exploratory analyses of cortical excitability measures showed bilateral trends toward facilitation; however, these changes did not reach statistical significance. Conclusion tFUS was safe and well tolerated in subacute stroke patients, with only minor transient AEs and no evidence of structural or neuropsychological harm. tFUS demonstrated potential to enhance upper limb motor recovery and functional outcomes. Although exploratory analyses suggested trends toward cortical excitability changes, these findings were not statistically significant and require confirmation in larger controlled trials.

Urinary tract infections (UTIs) are a major complication in patients with acute-to-subacute stroke. Asymptomatic bacteriuria is prevalent in this population, and the role of prophylactic antibiotics remains unclear. This study evaluated whether prophylactic antibiotics reduces the incidence of symptomatic UTI in patients with acute-to-subacute stroke with asymptomatic bacteriuria. This retrospective cohort study analyzed 111 patients with acute-to-subacute stroke and asymptomatic bacteriuria at a Taiwanese medical center. Participants were stratified into intervention ( n  = 38, receiving oral prophylactic antibiotics) and control ( n  = 73, no antibiotics) groups. The study compared the incidence of urinary tract infections between two groups. A subgroup analysis of subacute patients with stroke was performed to confirm the antibiotics’ protective effect. UTI incidence in the intervention and control groups were 2.7% and 32.73%, respectively ( p  = 0.003). Multivariate logistic regression revealed a 93% reduced risk of symptomatic UTI in the intervention versus the control group ( p  = 0.025). Subgroup analysis demonstrated the persistent protective effect of oral prophylactic antibiotics ( p  = 0.036). Prophylactic antibiotic treatment effectively reduced symptomatic UTI incidence among patients with acute-to-subacute stroke with asymptomatic bacteriuria. Future multicenter randomized controlled trials are warranted to standardize treatment protocols and evaluate long-term outcomes in this vulnerable population.

It is unclear whether muscle coactivation during gait is altered early after stroke and among which muscles. We sought to characterize muscle coactivation during gait in subacute stroke subjects without hypertonia and explore the relationship with temporospatial parameters. In 70 stroke (23 ± 12 days post-onset) and 29 age-matched healthy subjects, surface electromyography signals were used to calculate coactivation magnitude and duration between rectus femoris and medial hamstring (knee antagonistic coactivation), tibialis anterior and medial gastrocnemius (ankle antagonistic coactivation), and rectus femoris and medial gastrocnemius (extensor synergistic coactivation) during early double-support (DS1), early single-support (SS1), late single-support (SS2), late double-support (DS2), and swing (SW). Compared to both free and very-slow speeds of controls, stroke subjects had bilaterally decreased ankle coactivation magnitude in SS2 and duration in SS1 and SS2 as well as increased extensor coactivation magnitude in DS2 and SW. Both non-paretic knee and ankle coactivation magnitudes in SS2 moderately correlated with most temporospatial parameters (|r| ≥ 0.40). Antagonistic and synergistic coactivation patterns of the knee and ankle muscles during gait are altered bilaterally in subacute stroke subjects without lower limb hypertonia suggesting impairments in motor control. Greater coactivation magnitudes in the non-paretic knee and both ankles during the terminal stance (SS2) are associated with the overall worse gait performance. Unlike previously reported excessive coactivation or no change in chronic stroke, bilaterally decreased and increased coactivation patterns are present in subacute stroke. These findings warrant longitudinal studies to examine the evolution of changes in muscle coactivation from subacute to chronic stroke.

Background and objectives Poststroke pain (PSP) is a prevalent and severe consequence of stroke, encompassing central, neuropathic, and nonneuropathic pain. In this study, we aimed to investigate clinical factors associated with PSP three months after stroke and concurrently explore the association between PSP and one-year mortality. Methods This registry-based study comprised data from stroke patients admitted to three hospitals in Sweden between November 2014 and June 2019. The outcome was PSP three months after stroke. Twelve (out of 28) predictor variables were selected by three machine learning methods, and a multivariable binary logistic regression model was fitted for predicting PSP. The association between PSP and one-year poststroke mortality was examined using Cox proportional hazards models. Results Among 4,160 stroke patients participating in the three-month follow-up, 54.7% reported PSP. Antiplatelet use, diabetes, hemiparesis, sensory deficits, and need for assistance before stroke were significant predictors of PSP. Male sex, being born in Sweden, higher income, and regular prestroke physical activity predicted the absence of PSP. After adjustment for age, sex, region of birth, and stroke severity, patients experiencing PSP had a significantly higher one-year mortality rate than those without pain, and the most severe level of pain (constant pain) was associated with the highest cumulative mortality. Conclusion The study findings indicate treatable factors associated with PSP, which highlight areas of improvement in management strategies. Clinicians should recognize that PSP is associated with increased one-year mortality, emphasizing the importance of pain prevention and treatment for enhanced poststroke outcomes.

Background: The trunk acts as proximal support with which limbs execute smooth and purposeful movement. Furthermore, as upper extremity functions are an integral component of daily living activities, exploring the association between trunk and upper extremity recovery will guide therapists in developing appropriate rehabilitation goals and interventions. The objectives of this study were to (1) assess the association between trunk and upper extremity recovery in the subacute stroke population and (2) assess the effect of trunk control on upper extremity impairment and function with age, gender, and duration of stroke as mediators using mediation analysis in subacute stroke individuals. Methods: This cross-sectional study included 54 subacute stroke participants with a mean age of 58.37 ± 6.11 years. The trunk impairment scale (TIS) assessed the trunk’s stability, mobility, and coordination. The level of upper extremity impairment was evaluated using the Fugl-Meyer Assessment scale (FMA). The quality and quantity of upper limb motor functions were measured using the Wolf motor function test (WMFT). Results: The TIS exhibited moderate positive correlations with the FMA-UE, WMFT-time scale (TS), and WMFT-functional ability scale (FAS) at p < 0.001. The mediation analysis reported a profound mediation effect of post-stroke duration on the association of trunk and upper limb recovery. Conclusions: The study results substantiated that trunk control significantly correlates with upper limb impairment and the quality and quantity of its use in the subacute stroke population. Post-stroke duration proved to mediate the association between trunk and upper limb recovery. Therefore, the assessment and intervention of trunk and upper extremity motor control considering the post-stroke duration is vital and should be incorporated in stroke rehabilitation aiming at functional independence.